Factors associated with potential over- and undertreatment of hyperglycaemia and annual measurement of HbA
Aged
Biomarkers
/ blood
Blood Glucose
/ metabolism
Cross-Sectional Studies
Diabetes Mellitus, Type 2
/ blood
Female
Follow-Up Studies
General Practice
Glycated Hemoglobin
/ analysis
Humans
Hyperglycemia
/ blood
Hypoglycemic Agents
/ therapeutic use
Incidence
Insulin
/ therapeutic use
Male
Middle Aged
Norway
/ epidemiology
Retrospective Studies
HbA1c
family medicine
general practice
overtreatment
type 2 diabetes
undertreatment
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
11
11
2020
received:
26
07
2020
accepted:
14
12
2020
pubmed:
24
12
2020
medline:
30
3
2022
entrez:
23
12
2020
Statut:
ppublish
Résumé
To identify individual and general practitioner (GP) characteristics associated with potential over- and undertreatment of hyperglycaemia in type 2 diabetes and with HbA A cross-sectional study that included 10233 individuals with type 2 diabetes attending 282 GPs. Individuals with an HbA Overall, 4.1% were potentially overtreated, 7.8% were potentially undertreated and 11% did not have HbA Potential overtreatment in elderly individuals with type 2 diabetes was relatively low. Nevertheless, appropriate de-intensification or intensification of treatment and regular HbA
Identifiants
pubmed: 33354827
doi: 10.1111/dme.14500
pmc: PMC8359382
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14500Informations de copyright
© 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Références
BMJ. 2011 Nov 24;343:d6898
pubmed: 22115901
JAMA Intern Med. 2015 Mar;175(3):356-62
pubmed: 25581565
Endocr Pract. 2019 Dec;25(12):1317-1322
pubmed: 31412226
Diabetes Care. 2013 Sep;36(9):2628-38
pubmed: 23628621
Cardiovasc Diabetol. 2015 Aug 07;14:100
pubmed: 26249018
Diabetes Educ. 2007 Nov-Dec;33(6):1014-29; discussion 1030-1
pubmed: 18057270
Diab Vasc Dis Res. 2017 May;14(3):172-183
pubmed: 28467203
Diabetes Care. 2018 Jun;41(6):1121-1124
pubmed: 29784695
Diabet Med. 2013 May;30(5):e170-7
pubmed: 23350893
Diabetes Care. 2013 Nov;36(11):3411-7
pubmed: 23877982
Ther Adv Endocrinol Metab. 2019 May 03;10:2042018819844694
pubmed: 31105931
Scand J Prim Health Care. 2018 Jun;36(2):170-179
pubmed: 29717939
Diabetologia. 2018 Jul;61(7):1503-1516
pubmed: 29417185
PLoS Med. 2020 May 15;17(5):e1003106
pubmed: 32413037
Lancet Diabetes Endocrinol. 2017 Jun;5(6):431-437
pubmed: 28365411
J Am Geriatr Soc. 2018 Jul;66(6):1190-1194
pubmed: 29633237
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Acta Diabetol. 2017 Feb;54(2):209-214
pubmed: 27837286
BMJ Open Diabetes Res Care. 2017 Nov 08;5(1):e000459
pubmed: 29177051
Diabetes Res Clin Pract. 2012 Sep;97(3):377-84
pubmed: 22763108
Diabetologia. 2018 Dec;61(12):2461-2498
pubmed: 30288571
Lancet Diabetes Endocrinol. 2018 Apr;6(4):266-268
pubmed: 29033057
Diabet Med. 2015 Mar;32(3):407-13
pubmed: 25251768
J Health Commun. 2013;18 Suppl 1:172-84
pubmed: 24093354
Int J Cardiol. 2016 Sep 1;218:50-58
pubmed: 27236108
Diabetologia. 2009 Nov;52(11):2288-98
pubmed: 19655124
Med Care. 2013 Feb;51(2):172-9
pubmed: 23222526
Adv Ther. 2018 Nov;35(11):1735-1745
pubmed: 30374807